ASK REDCHAT ANYTHING ABOUT XBIOTECH INC.
XBiotech Inc. (NASDAQ: XBIT)
Listen to this Section
$2.36
-0.0550
(
-2.28% )
26.2K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| NatrunixDetailsRheumatoid arthritis, Autoimmune disease |
Phase 2 |
| Natrunix (XB2001) w/ ON+5FU+LVDetailsCancer, Pancreatic cancer |
Phase 1/2 |
| HutrukinDetailsBrain disease, Ischemic stroke |
Phase 1 |
| Natrunix + trifluridine/tipiracilDetailsCancer, Colorectal cancer |
Phase 1 |
| BermekimabDetailsSkin disease/disorder, Hidradenitis suppurativa |
Failed |
| BermekimabDetailsSkin disease/disorder |
Failed |
| 514G3DetailsBacterial infection, Methicillin-resistant staphylococcus aureus |
Failed |
Market Data
|
| Open |
$2.36 |
| Previous Close |
$2.41 |
| Volume |
26.2K |
| Market Cap |
$73.48M |
| Day Range |
$2.36 - $2.42 |
| 52 Week Range |
$2.09 - $3.61 |
| Shares Outstanding |
30.49M |
| Change % |
-2.28% |
| Net Change |
▼ -0.0550 |
| Insider Ownership |
N/A |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2015 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
2,320,355.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-06-21 |
Sale |
-37500.00 |
Libby Peter |
| 2024-06-21 |
Sale |
-37500.00 |
MacAdam Donald H. |
| 2024-06-21 |
Sale |
-37500.00 |
Waldin Jan-Paul |
| 2024-06-21 |
Sale |
-37500.00 |
MCKENZIE W THORPE |
| 2024-01-05 |
Buy |
2470355.00 |
SIMARD JOHN |